Pharmacyte Biotech, Inc. (PMCB) — 10-K Filings
All 10-K filings from Pharmacyte Biotech, Inc.. Browse 2 Annual Report reports with AI-powered summaries and risk analysis.
10-K Filings (2)
-
PharmaCyte Biotech Acquires Femasys, Eyes New Growth Avenues
— Aug 11, 2025 Risk: high
PharmaCyte Biotech, Inc. reported no revenue for the fiscal year ended April 30, 2025, consistent with its development-stage status. The company's net loss for -
PharmaCyte Biotech Files Annual 10-K
— Aug 13, 2024 Risk: medium
PharmaCyte Biotech, Inc. filed its 10-K for the fiscal year ending April 30, 2024. The company, formerly known as NuVilex, Inc., is focused on biological produc
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX